Drug class
Gadolinium-based paramagnetic magnetic-resonance imaging (MRI) contrast agent
Mechanism of action
A gadolinium-DTPA chelate that produces a paramagnetic effect in a magnetic field, shortening the T1 and T2 relaxation times of nearby water protons and enhancing MRI signal.
General use cases
- Contrast enhancement during MRI of intracranial lesions with abnormal vascularity or abnormalities of the blood-brain barrier, as described in product information.
The active imaging entity is the intact gadolinium–DTPA chelate, not free gadolinium or meglumine. This is a coordination complex/radiology contrast agent; do not merge with other gadolinium chelates.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
